Business Context and Reporting Period
This Form 6-K filing covers the month of July 2025 for Majestic Ideal Holdings Ltd, a foreign private issuer. The filing reports on the completion of the company's Initial Public Offering (IPO). Note: The input metadata references "Ping An Biomedical Co., Ltd.", but the filing text explicitly identifies the registrant as "Majestic Ideal Holdings Ltd."
Key Financial Metrics
The filing details the terms of the IPO but does not provide historical revenue, profit, cash flow, or debt metrics.
- Shares Offered: 2,500,000 ordinary shares.
- Offering Price: $6.00 per share.
- Par Value: $0.0000625 per share.
- Total Gross Proceeds: $15,000,000 (calculated from share count and price).
- Underwriters: Craft Capital Management, LLC and WestPark Capital, Inc.
Material Changes
The primary material change is the transition from a private entity to a public company following the IPO.
- July 17, 2025: Entered into an underwriting agreement and announced the pricing of the IPO.
- July 22, 2025: Announced the closing of the IPO.
- Corporate Governance: Adopted a code of business conduct and ethics, audit committee charter, compensation committee charter, nominating committee charter, and an insider trading policy in connection with the IPO.
Guidance, Outlook, and Risks
The filing text does not provide specific financial guidance, future outlook projections, or a detailed discussion of risks and contingencies beyond the standard disclosure of the IPO completion and governance adoption.
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting discounts and offering expenses (not explicitly stated in this summary).
- Confirm the ticker symbol and listing exchange for the newly issued ordinary shares.
- Review the full Registration Statement on Form F-1 (File No. 333-282499) for detailed risk factors and use of proceeds.
- Check for any lock-up agreements or restrictions on share sales by insiders post-IPO.